4//SEC Filing
SCIASCIA THOMAS 4
Accession 0000950170-25-045295
CIK 0001563880other
Filed
Mar 25, 8:00 PM ET
Accepted
Mar 26, 4:30 PM ET
Size
8.3 KB
Accession
0000950170-25-045295
Insider Transaction Report
Form 4
SCIASCIA THOMAS
Chief Scientific Officer
Transactions
- Exercise/Conversion
Common Stock
2025-03-25$1.43/sh+2,631$3,762→ 224,004 total - Exercise/Conversion
Stock Option (right to buy)
2025-03-25−2,631→ 0 totalExercise: $1.43Exp: 2025-05-14→ Common Stock (2,631 underlying) - Sale
Common Stock
2025-03-25$6.60/sh−2,631$17,365→ 221,373 total
Footnotes (2)
- [F1]Includes 1,058 shares purchased through the Issuer's employee stock purchase plan.
- [F2]This option was granted on May 15, 2015. The 2,631 shares of common stock underlying the option vested as to 25% of the shares on May 15, 2016 and vested as to the remaining 75% of the shares in equal monthly installments thereafter through May 15, 2019.
Documents
Issuer
Trevi Therapeutics, Inc.
CIK 0001563880
Entity typeother
Related Parties
1- filerCIK 0001229946
Filing Metadata
- Form type
- 4
- Filed
- Mar 25, 8:00 PM ET
- Accepted
- Mar 26, 4:30 PM ET
- Size
- 8.3 KB